Needham upgraded ResMed to Buy from Hold with an $180 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on RMD:
- ResMed Announces Participation in Upcoming Conferences
- Lowe’s upgraded, General Mills downgraded: Wall Street’s top analyst calls
- ResMed downgraded to Neutral from Buy at UBS
- Early notable gainers among liquid option names on August 30th
- Early notable gainers among liquid option names on August 15th